Suppr超能文献

小切口透镜切除术(SMILE)后准分子原位角膜磨镶术增效(PRK)

Photorefractive Keratectomy Enhancement (PRK) After Small-Incision Lenticule Extraction (SMILE).

作者信息

Moshirfar Majid, Parsons Mark T, Chartrand Nicholas A, Lau Chap-Kay, Stapley Seth, Bundogji Nour, Ronquillo Yasmyne C, Hoopes Phillip C

机构信息

Hoopes Vision Research Center, Hoopes Vision, Draper, UT, USA.

John A. Moran Eye Center, University of Utah School of Medicine, Salt Lake City, UT, USA.

出版信息

Clin Ophthalmol. 2022 Sep 12;16:3033-3042. doi: 10.2147/OPTH.S381319. eCollection 2022.

Abstract

PURPOSE

To determine rates of enhancement and visual prognosis following photorefractive keratectomy (PRK) enhancement of small-incision lenticule extraction (SMILE).

PATIENTS AND METHODS

This retrospective, single-site study reviewed all cases of primary SMILE at Hoopes Vision in Draper, Utah between March 14, 2017 and April 8, 2022 to identify any cases that required follow-up enhancement. Primary SMILE was performed using Visumax 500 kHz femtosecond laser (Carl Zeiss Meditec, Jena, Germany). All enhancements were performed with alcohol-assisted PRK, using a WaveLight EX500 excimer laser (Alcon Laboratories, Inc., Fort Worth, TX).

RESULTS

Four hundred and five eyes underwent primary SMILE, of which 15 later underwent PRK enhancement (enhancement rate of 3.7%). No significant difference in pre-SMILE data was identified between the enhancement and non-enhancement groups. The average age of those who underwent PRK enhancement was 33.8±6.3 years old and ranged from 25 to 45. Following primary SMILE, 13 eyes (87%) had an uncorrected distance visual acuity (UDVA) of 20/40 or better, and none had a UDVA of 20/20 or better. After one year of post-enhancement follow-up, all eyes had a UDVA of 20/40 or better, and 13 eyes (87%) had a UDVA of 20/20 or better (Figure 1). All were within one diopter of target spherical equivalent (SEQ), 13 (87%) were within 0.50 D, and 10 (67%) were within 0.25 D. Of those with 12-month follow-up data, none had UDVA worse than corrected distance visual acuity (CDVA), and none had lost lines of CDVA. Efficacy and safety indices were 1.03 and 0.99, respectively.

CONCLUSION

Following SMILE, ophthalmologists may anticipate an enhancement rate of one to seven percent. In these cases, PRK is a safe and effective procedure for enhancement of SMILE.

摘要

目的

确定小切口透镜切除术(SMILE)后行准分子原位角膜磨镶术(PRK)强化后的增强率和视觉预后。

患者和方法

这项回顾性单中心研究回顾了2017年3月14日至2022年4月8日期间在犹他州德雷珀市胡普斯视力中心进行的所有原发性SMILE病例,以确定任何需要后续强化的病例。原发性SMILE使用Visumax 500 kHz飞秒激光(德国耶拿卡尔蔡司医疗技术公司)进行。所有强化手术均采用酒精辅助PRK,使用威视EX500准分子激光(美国德克萨斯州沃思堡爱尔康实验室公司)。

结果

405只眼接受了原发性SMILE,其中15只眼后来接受了PRK强化(强化率为3.7%)。强化组和未强化组在SMILE术前数据方面未发现显著差异。接受PRK强化的患者平均年龄为33.8±6.3岁,年龄范围为25至45岁。原发性SMILE后,13只眼(87%)的未矫正远视力(UDVA)为20/40或更好,且没有一只眼的UDVA为20/20或更好。强化后随访一年,所有眼睛的UDVA均为20/40或更好,13只眼(87%)的UDVA为20/20或更好(图1)。所有眼睛的等效球镜度(SEQ)均在目标值的1屈光度以内,13只眼(87%)在0.50 D以内,10只眼(67%)在0.25 D以内。在有12个月随访数据的患者中,没有一只眼的UDVA比矫正远视力(CDVA)差,也没有一只眼的CDVA下降。疗效指数和安全指数分别为1.03和0.99。

结论

SMILE术后,眼科医生可预期强化率为1%至7%。在这些病例中,PRK是强化SMILE的一种安全有效的手术方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0faf/9480579/e1e86f1bd1b1/OPTH-16-3033-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验